Anti-graft probes into drug makers: GSK lessons
Jun 23, 2014
TOP TIPS: Anti-graft compliance for drug industry
As allegations of GlaxoSmithKline corruption spreads across the globe, China consultants at Protiviti advise on how to effectively screen drug suppliers and perform better internal control.
China’s Ministry of Public Security is set to update journalists on the alleged corrupt activities of GlaxoSmithKline (GSK) today. The saga of GSK and ongoing investigations is again in the spotlight.
Sign in to read on!
Registered users get 2 free articles in 30 days.
Subscribers have full unlimited access to CorporateTreasurer.
Not signed up? New users get 2 free articles per month, plus a 7-day unlimited free trial.
If you are a treasurer, CFO or senior financial professional at a corporate or SME, please register for free VIP access here.
Questions?
See here for more information on licences and prices, or contact [email protected].
© Haymarket Media Limited. All rights reserved.
Top news, insights and analysis every Tuesday & Thursday
Free registration gives you access to our email newsletters
for unlimited access to all articles, newsletters
